HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Izumiya Selected Research

Necrosis

6/2014Dienogest improves human leucocyte antigen-DR underexpression and reduces tumour necrosis factor-α production in peritoneal fluid cells from women with endometriosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C Izumiya Research Topics

Disease

1Endometriosis
06/2014
1Necrosis
06/2014
1Melanoma (Melanoma, Malignant)
09/2004
1Amelanotic Melanoma (Amelanotic Melanomas)
09/2004

Drug/Important Bio-Agent (IBA)

1dienogestFDA Link
06/2014
1AntigensIBA
06/2014
1EnzymesIBA
06/2014
1HLA-DR Antigens (HLA-DR)IBA
06/2014
1ImmunosorbentsIBA
06/2014
1S100 Proteins (S 100 Protein)IBA
09/2004
1Melanins (Melanin)IBA
09/2004